Human Genome Epidemiology Literature Finder
|
Records 1 - 23 (of 23 Records) |
| Query Trace: Disease and meta-analysis and BRAF[original query] |
|---|
| The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis. Cancer 2012 Apr 118 (7): 1764-73. Kim Tae Hyuk, Park Young Joo, Lim Jung Ah, Ahn Hwa Young, Lee Eun Kyung, Lee You Jin, Kim Kyung Won, Hahn Seo Kyung, Youn Yeo Kyu, Kim Kwang Hyun, Cho Bo Youn, Park Do Jo |
| BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis. Medicine 2012 Aug . Tufano RP, Teixeira GV, Bishop J, Carson KA, Xing M |
| Prognostic value of genetic mutations in thyroid cancer: a meta-analysis. Thyroid : official journal of the American Thyroid Association 2015 Jan 25 (1): 63-70. Pak Kyoungjune, Suh Sunghwan, Kim Seong Jang, Kim In-J |
| BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis. PloS one 2014 9 (3): e90607. Chen Dong, Huang Jun-Fu, Liu Kai, Zhang Li-Qun, Yang Zhao, Chuai Zheng-Ran, Wang Yun-Xia, Shi Da-Chuan, Huang Qing, Fu Wei-Li |
| BRAF(V600E) Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis. Thyroid : official journal of the American Thyroid Association 2015 Dec . Chen Yufei, Sadow Peter M, Suh Hyunsuk, Lee Kyu Eun, Choi June Young, Suh Yong Joon, Wang Tracy S, Lubitz Carrie Cunningh |
| Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials. PloS one 2016 11 (5): e0154795. Zhu Lizhen, Dong Caixia, Cao Ying, Fang Xuefeng, Zhong Chenhan, Li Dan, Yuan Yi |
| A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis. Oncotarget 2016 Dec . Liu Zeming, Zeng Wen, Chen Tianwen, Guo Yawen, Zhang Chao, Liu Chunping, Huang T |
| Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis. OncoTargets and therapy 2016 9 6965-6976. Su Xingyun, Jiang Xiaoxia, Wang Weibin, Wang Haiyong, Xu Xin, Lin Aihui, Teng Xiaodong, Wu Huiling, Teng Liso |
| THE RELATIONSHIP OF BRAF MUTATION STATUS TO FDG PET/CT AVIDITY IN THYROID CANCER: A REVIEW AND META-ANALYSIS. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2017 11 24 (1): 21-26. Santhanam Prasanna, Khthir Rodhan, Solnes Lilja B, Ladenson Paul |
| Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials. British journal of cancer 2017 Dec 117 (12): 1768-1776. Goey Kaitlyn K H, Elias Sjoerd G, Hinke Axel, van Oijen Martijn G H, Punt Cornelis J A, Hegewisch-Becker Susanna, Arnold Dirk, Koopman Miri |
| Genetic homogeneity of adult Langerhans cell histiocytosis lesions: Insights from BRAF mutations in adult populations. Oncology letters 2017 11 14 (4): 4449-4454. Selway Joanne Louise, Harikumar Parvathy Elacode, Chu Anthony, Langlands Kenne |
| Comparative Efficacy of Treatments for Previously Treated Advanced or Metastatic Non-Small-Cell Lung Cancer: A Network Meta-Analysis. Advances in therapy 2018 6 35 (7): 1035-1048. Li Junlong, Sasane Medha, Zhao Jing, Horton Viviana Garcia, Zhang Pingkuan, Ricculli Marie Louise, Zhou Zheng-Yi, Signorovitch Jam |
| PIK3CA mutation and clinicopathological features of colorectal cancer: a systematic review and Meta-Analysis. Acta oncologica (Stockholm, Sweden) 2019 9 59 (1): 66-74. Jin Juan, Shi Yaqin, Zhang Shu, Yang Shuof |
| Clinicopathological Significance of BRAF Mutation in Colorectal Cancer: An Updated Meta-Analysis. Journal of Cancer 2019 7 10 (10): 2332-2341. Wang Jianhua, Shen Jiajia, Huang Chi, Cao Meng, Shen Lizo |
| Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China. Diagnostic pathology 2019 Jul 14 (1): 74. Huang Meiling, Yan Changjiao, Xiao Jingjing, Wang Ting, Ling R |
| Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis. Cancer medicine 2019 Dec . Bylsma Lauren C, Gillezeau Christina, Garawin Tamer A, Kelsh Michael A, Fryzek Jon P, Sangaré Laura, Lowe Kimberly |
| BRAF mutational status as a prognostic marker for survival in malignant melanoma: a systematic review and meta-analysis. Acta oncologica (Stockholm, Sweden) 2020 4 59 (7): 833-844. Ny L, Hernberg M, Nyakas M, Koivunen J, Oddershede L, Yoon M, Wang X, Guyot P, Geisler |
| The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis. Frontiers in oncology 2020 10 540238. Zhao Ling, Wang Lin, Jia Xiaomeng, Hu Xiaodong, Pang Ping, Zhao Sitong, Wang Yajing, Wang Jing, Zhang Yingshi, Lyu Zhaoh |
| Reevaluating the prognostic role of BRAF mutation in colorectal cancer liver metastases. American journal of surgery 2021 Sep . Pikouli Anastasia, Papaconstantinou Dimitrios, Wang Jane, Kavezou Foteini, Pararas Nikolaos, Nastos Constantinos, Pikoulis Emmanouil, Margonis Georgios Antoni |
| Genetics and clinical phenotype of Erdheim-Chester disease: A case report of constrictive pericarditis and a systematic review of the literature. Frontiers in cardiovascular medicine 2022 9 876294. Bartoli Lorenzo, Angeli Francesco, Stefanizzi Andrea, Fabrizio Michele, Paolisso Pasquale, Bergamaschi Luca, Broccoli Alessandro, Zinzani Pier Luigi, Galiè Nazzareno, Rucci Paola, Foà Alberto, Pizzi Carmi |
| The challenge of molecular selection in liver-limited metastatic colorectal cancer for surgical resection: a systematic review and meta-analysis in the context of current and future approaches. Oncology research 2024 9 32 (9): 1407-1422. Rossana Roncato, Jerry Polesel, Federica Tosi, Elena Peruzzi, Erika Brugugnoli, Claudia Lauria Pantano, Maria Furfaro, Filippo DI Girolamo, Alessandro Nani, Arianna Pani, Noemi Milan, Elena DE Mattia, Andrea Sartore-Bianchi, Erika Cecch |
| Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: A systematic review and meta-analysis. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2024 6 50 (9): 108474. Ziming Gao, Xiang Qi, Ruiying Wang, Zhitong Wen, Hao Qi, Mingguang Ju, Xiaoxu Liu, Junye Wang, Heng Zhou, Zhi Zhu, Xiaofang Liu, Kai |
| Efficacy and safety of BRAF/MEK inhibitors in BRAFV600E-mutated anaplastic thyroid cancer: a systematic review and meta-analysis. Endocrine 2024 5 . Jonathan N Priantti, Natasha Maranhão Vieira Rodrigues, Francisco Cezar Aquino de Moraes, Allyson Guimarães da Costa, Deborah Laredo Jezini, Maria Izabel Ovellar Heckma |
- Page last reviewed:Feb 1, 2024
- Content source: